Answers are grounded in this paper and cite their sources.
This study aimed to identify species identification, molecular typing, and drug resistance characterization of clinically isolated mycobacteria from Anhui, Fujian, and Hunan provinces, and to evaluate the value of whole-genome sequencing (WGS) in predicting drug resistance. WGS and phenotypic drug susceptibility testing (DST) were performed on clinical Mycobacterium isolates from those provinces. Bioinformatics analysis and chi-square test were used to compare inter-provincial differences in drug resistance and lineages. Of the 1,383 isolates, 95.30% belonged to the MTBC and 3.40% were NTM. Lineage 2 (74.07%) and lineage 4 (24.94%) were dominant in MTBC. The overall drug resistance rate was 32.08%, while MDR rate was 11.14%. Hunan had significantly higher MDR and RIF resistance rates than the other provinces ( p < 0.05). INH had the highest resistance rate (19.37%). Fluoroquinolones exhibited significant inter-provincial differences in resistance rates. WGS exhibited >85% sensitivity and >96% specificity for first-line drug resistance prediction, and >77% sensitivity and >97% specificity for second-line drug resistance. Additionally, 87.92% of isolates showed consistent genotypic and phenotypic DST results. MTBC isolates exhibited pronounced inter-provincial variation in lineage composition. Geographical differences existed in drug resistance, particularly for MDR and RIF resistance. WGS was reliable for predicting first-line drug resistance, but unknown resistance mechanisms were detected, requiring further exploration to optimize prediction.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: